Old and New NICE Guidelines for the Evaluation of New Onset Stable Chest Pain: A Real World Perspective.

Nazario Carrabba, Angela Migliorini, Silvia Pradella, Manlio Acquafresca, Marco Guglielmo, Andrea Baggiano, Giuseppe Moscogiuri, Renato Valenti

Journal: BioMed research international 2019;2018():3762305

PMID: 30533431

Abstract

Stable chest pain is a common clinical presentation that often requires further investigation using noninvasive or invasive testing, resulting in a resource-consuming problem worldwide. At onset of 2016, the National Institute for Health and Care Excellence (NICE) published an update on its guideline on chest pain. Three key changes to the 2010 version were provided by the new NICE guideline. First, the new guideline recommends that the previously proposed pretest probability risk score should no longer be used. Second, they also recommend that a calcium score of zero should no longer be used to rule out coronary artery disease (CAD) in patients with low pretest probability. Third, the new guideline recommends that all patients with new onset chest pain should be investigated with a coronary computed tomographic angiography (CTA) as a first-line investigation. However, in real world the impact of implementation of CTA for the evaluation of new onset chest pain remains to be evaluated, especially regarding its cost effectiveness. The aim of the present report was to discuss the results of the studies supporting new NICE guideline and its comparison with European and US guidelines.

Address: Cardiovascular and Thoracic Department of Careggi Hospital, Florence, Italy.; Radiologic Department of Careggi Hospital, Florence, Italy.; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.